ArticleAmerican journal of preventive cardiology2026
Screening for high coronary plaque volume in primary prevention: integration of multi-omics and coronary calcium scoring into cardiovascular risk assessment.
Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atherosclerotic plaque volume (PV) predicts future cardiovascular events. As coronary computed tomography angiography (CCTA) is unsuitable for population screening, individuals with high total (T)PV often remain undetected. Objective: To evaluate the relative and incremental contributions of lipidomic risk score (LRS), polygenic risk score (PRS), and coronary artery calcium score (CAC) improves screening for high TPV. Methods: Primary prevention participants in two trials underwent clinical assessment, CAC, and blood sampling for LRS and PRS. CCTA was obtained in participants with CAC>0 and ≤400. Associations between risk scores and TPV were assessed using linear regression. Logistic regression identified predictors of high TPV; model performance was evaluated using area under the curve (AUC), net reclassification index (NRI), and integrated discrimination index (IDI). Results: In the development cohort ( Conclusion: CAC was the dominant determinant of high coronary plaque volume and accounted for the majority of predictive performance. LRS and PRS provided only modest incremental value beyond CAC and clinical risk, supporting their role as complementary rather than primary screening tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.